Polomar Health Services (PMHS) Stock Overview
Operates as a retail compounding pharmacy. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
PMHS Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Polomar Health Services, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.42 |
| 52 Week High | US$1.50 |
| 52 Week Low | US$0.07 |
| Beta | 0 |
| 1 Month Change | 8.10% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -68.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| PMHS | US Consumer Retailing | US Market | |
|---|---|---|---|
| 7D | 0% | -0.5% | 0.6% |
| 1Y | n/a | 22.7% | 12.4% |
Return vs Industry: Insufficient data to determine how PMHS performed against the US Consumer Retailing industry.
Return vs Market: Insufficient data to determine how PMHS performed against the US Market.
Price Volatility
| PMHS volatility | |
|---|---|
| PMHS Average Weekly Movement | n/a |
| Consumer Retailing Industry Average Movement | 5.3% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in US Market | 17.1% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: PMHS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine PMHS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 3 | Terrence Tierney | polomarsp.com |
Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker’s nevus, vitiligo, and other common skin conditions.
Polomar Health Services, Inc. Fundamentals Summary
| PMHS fundamental statistics | |
|---|---|
| Market cap | US$11.66m |
| Earnings (TTM) | -US$1.64m |
| Revenue (TTM) | US$49.76k |
Is PMHS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PMHS income statement (TTM) | |
|---|---|
| Revenue | US$49.76k |
| Cost of Revenue | US$18.38k |
| Gross Profit | US$31.37k |
| Other Expenses | US$1.67m |
| Earnings | -US$1.64m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.059 |
| Gross Margin | 63.05% |
| Net Profit Margin | -3,291.50% |
| Debt/Equity Ratio | 16.1% |
How did PMHS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/09 06:40 |
| End of Day Share Price | 2025/06/27 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Polomar Health Services, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.